Skip to main content

Botulinum toxin type A in the management of headache: a review of the literature and personal experience

Abstract

Botulinum toxin type A (BoNT-A) shows significant promise in the management of a variety of headache types including migraine, chronic daily headache, tension-type headache, and other head and neck pains. Confirmation of efficacy still awaits the report of well-controlled double-blind placebo-controlled trials; however, a mounting body of evidence suggests that BoNT-A is effective, well-tolerated and safe for the management of many headache disorders. In this paper, I review recent evidence on the efficacy of BoNT-A, and also report my personal experience with the treatment in over 600 headache patients.

Author information

Affiliations

Authors

Corresponding author

Correspondence to B. Todd Troost.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Troost, B.T. Botulinum toxin type A in the management of headache: a review of the literature and personal experience. J Headache Pain 5, 15–22 (2004). https://doi.org/10.1007/s10194-004-0063-z

Download citation

Key words

  • Botulinum toxin type A
  • BoNT-A
  • Headache
  • Chronic daily headache
  • Tension headache